DIVE - ETF AI Analysis
Top Page
Dana Concentrated Dividend ETF (DIVE)
DIVE, the Dana Concentrated Dividend ETF, has a solid overall rating driven mainly by strong, growth-focused holdings like Salesforce, Meta Platforms, and Elevance Health, which benefit from healthy financial performance, positive earnings sentiment, and promising strategic initiatives in AI and healthcare technology. However, some key positions such as Philip Morris, AbbVie, and Keurig Dr Pepper face challenges including high leverage, valuation concerns, and bearish technical trends, and the fund’s concentrated mix of a few large positions increases risk if any of these core holdings stumble.
DIVE vs. SPDR S&P 500 ETF (SPY)
- AUM
- 48.10M
- Region
- North America
- Expense Ratio
- 0.65%
- Beta
- 0.55
- Issuer
- Dana
- Inception Date
- Sep 15, 2025
- Dividend Yield
- 1.26%
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
DIVE Summary
The Dana Concentrated Dividend ETF (DIVE) is an actively managed fund that focuses on large U.S. companies that pay dividends, aiming to provide both growth and regular income. It doesn’t track a specific index, but instead selects a smaller group of stocks across many sectors, including health care, technology, and consumer companies. Well-known holdings include Amazon and Philip Morris. Someone might invest in DIVE to get diversified exposure to established dividend-paying businesses in one simple investment. A key risk is that the fund holds a concentrated set of stocks, so its value can go up or down more sharply with the market and with those specific companies.
How much will it cost me?
This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 you invest. That’s higher than the average ETF cost because DIVE is actively managed, with professionals selecting and monitoring a concentrated portfolio of dividend-paying stocks.
What would affect this ETF?
DIVE could benefit if the U.S. economy stays resilient, supporting large health care, consumer defensive, and technology companies like Philip Morris, Keurig Dr Pepper, Amazon, and Salesforce, and if interest rates eventually stabilize or fall, making its dividend focus more attractive. On the downside, higher-for-longer interest rates, tighter consumer spending, or new regulations affecting health care, financials, or tobacco could pressure its income and growth, and its active, concentrated approach may lead to larger swings if a few big holdings struggle.
DIVE Top 10 Holdings
DIVE leans heavily on steady, dividend-rich U.S. large caps, with health care and consumer defensive names doing much of the heavy lifting. AbbVie and Elevance Health have been rising, giving the fund a solid health care backbone, while Philip Morris and Keurig Dr Pepper add a defensive, cash-generating flavor that’s also been supportive. On the growth side, Amazon looks more mixed, and Salesforce has been lagging, occasionally acting like a brake on returns. Overall, the ETF is U.S.-centric, blending resilient defensives with selective tech and financial exposure.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 PM | Philip Morris | 6.20% | $2.98M | $325.43B | 43.24% | 61Neutral |
 KDP | Keurig Dr Pepper | 5.27% | $2.53M | $48.77B | 29.48% | 71Outperform |
 IQV | IQVIA Holdings | 5.24% | $2.52M | $44.06B | 23.50% | 73Outperform |
 ELV | Elevance Health | 4.78% | $2.30M | $90.76B | 30.48% | 76Outperform |
 AMZN | Amazon | 4.75% | $2.28M | $2.59T | 7.85% | 71Outperform |
 QSR | Restaurant Brands International | 4.60% | $2.21M | $32.71B | 8.06% | 75Outperform |
 COF | Capital One Financial | 4.51% | $2.17M | $123.22B | -6.20% | 71Outperform |
 ABBV | AbbVie | 3.74% | $1.80M | $521.11B | 29.22% | 66Neutral |
 CRM | Salesforce | 3.67% | $1.77M | $188.61B | -10.71% | 80Outperform |
 ACN | Accenture | 3.49% | $1.68M | $152.63B | 3.61% | 79Outperform |
DIVE Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For DIVE, the sentiment is Positive. The current price of 28.22 is above the 20-day moving average (MA) of 27.75, above the 50-day MA of 27.63, and above the 200-day MA of 26.16, indicating a bullish trend. The MACD of 0.24 indicates Negative momentum. The RSI at 63.43 is Neutral, neither overbought nor oversold. The STOCH value of 64.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DIVE.
DIVE Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| DIVE | $28.22 | $30.00(6.32% Upside) | $48.10M | 0.65% | 72Outperform |
 PRMR | $28.30 | $35.01(23.68% Upside) | $93.31M | 1.00% | 73Outperform |
 FCUS | $36.61 | $47.35(29.34% Upside) | $87.54M | 0.80% | 67Neutral |
 REGS | $11.08 | $15.07(36.01% Upside) | $76.65M | 0.35% | 74Outperform |
 EGGQ | $43.39 | $71.98(65.89% Upside) | $79.45M | 0.93% | 58Neutral |
 SPCT | $27.98 | $32.09(14.69% Upside) | $71.86M | 0.85% | 72Outperform |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DIVE | Dana Concentrated Dividend ETF | 28.22 | 4.30 | 17.98% | |
| PRMR | PeakShares RMR Prime Equity ETF | 28.30 | 3.32 | 13.31% | |
| FCUS | Pinnacle Focused Opportunities ETF | 36.61 | 2.64 | 7.78% | |
| REGS | Columbia Large Cap Growth ETF | 11.08 | 0.99 | 9.84% | |
| EGGQ | NestYield Visionary ETF | 43.39 | -3.25 | -6.98% | |
| SPCT | Liberty One Spectrum ETF | 27.98 | 3.04 | 12.18% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.